Benjamin F. Edwards & Company, Inc. Ark Genomic Revolution ETF (De Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 482 shares of ARKG stock, worth $14,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
482
Previous 616
21.75%
Holding current value
$14,219
Previous $18,000
38.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
19.1MCall Options Held
3.93MPut Options Held
4.4M-
Jpmorgan Chase & CO New York, NY3.43MShares$101 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.18MShares$93.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.13MShares$62.7 Million0.0% of portfolio
-
Ubs Group Ag1.35MShares$39.9 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA1.09MShares$32.1 Million0.01% of portfolio